The Faces of Oral Cancer are Changing®

With the OncAlert Oral Cancer product line, you can know earlier and give patients a better later.™

The Faces of Oral Cancer are Changing®

With the OncAlert Oral Cancer product line, you can know earlier and give patients a better later.™

The Science of Earlier®

The OncAlert® Oral Cancer product line is comprised of proprietary tests that detect CD44 and total protein. These tests are optimized for easy use by collecting samples via an oral saline rinse. The test results, along with other clinical factors, can aid in the early diagnosis of oral cancer.

Featured News + Events

Media Coverage / June 26, 2017 / Read More
Vigilant Biosciences Commences Studies of Oral Cancer Test
News & Events / June 21, 2017 / Read More
Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert® Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual MASCC Meeting
Media Coverage / June 14, 2017 / Read More
Fort Lauderdale biotech firm gets federal grant for oral cancer study

View All